Clinical Trial Update: Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder [NA]

View source ↗

Summary

Clinical trial update on MR-C-014 for neuromyelitis optica spectrum disorder, focusing on acceptability and safety, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• MR-C-014

Snippet

Sponsor: MedRhythms, Inc. | Conditions: Neuromyelitis Optica Spectrum Disorder | NA | Status: ENROLLING_BY_INVITATION